Title : Tofacitinib suppresses mast cell degranulation and attenuates experimental allergic conjunctivitis.

Pub. Date : 2020 Sep

PMID : 32615452






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 RESULTS: Topical administration of tofacitinib reduced the clinical symptoms of OVA-induced EAC, with a substantial mitigation in inflammatory cell infiltration, histamine release, and TNF-alpha mRNA as well as IL-4 mRNA expression. tofacitinib tumor necrosis factor Rattus norvegicus